speb/financial-data huggingface dataset:
DPM.AX cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -28899000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 13521000.00
DPM.AX balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 13521000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Capital Stock: 547652000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 634830000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 634830000.00
DPM.AX cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -28919000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Cash Equivalents: 54500000.00
DPM.AX balance_sheet (quarterly, 2024-12-31) — Cash Equivalents: 54500000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Cash Financial: 580300000.00
DPM.AX balance_sheet (quarterly, 2024-12-31) — Cash Financial: 580300000.00
DPM.AX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -83087000.00
DPM.AX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -23904000.00
DPM.AX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 144712000.00
DPM.AX cash_flow (annual, 2024-12-31) — Cash From Discontinued Financing Activities: -1994000.00
DPM.AX cash_flow (quarterly, 2024-12-31) — Cash From Discontinued Financing Activities: 0.00
DPM.AX cash_flow (annual, 2024-12-31) — Cash From Discontinued Investing Activities: -3946000.00
DPM.AX cash_flow (quarterly, 2024-12-31) — Cash From Discontinued Investing Activities: 0.00
DPM.AX cash_flow (annual, 2024-12-31) — Cash From Discontinued Operating Activities: -152059000.00
DPM.AX cash_flow (quarterly, 2024-12-31) — Cash From Discontinued Operating Activities: -60917000.00
DPM.AX cash_flow (annual, 2024-12-31) — Change In Inventory: 15285000.00
DPM.AX cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -21104000.00
DPM.AX cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -12676000.00
DPM.AX cash_flow (annual, 2024-12-31) — Change In Receivables: -192899000.00
DPM.AX cash_flow (annual, 2024-12-31) — Change In Working Capital: -211394000.00
DPM.AX cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -192899000.00
DPM.AX cash_flow (annual, 2024-12-31) — Changes In Cash: 37721000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Common Stock: 547652000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Common Stock Equity: 1286828000.00
DPM.AX cash_flow (annual, 2024-12-31) — Common Stock Payments: -49881000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Construction In Progress: 11992000.00
DPM.AX balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 11992000.00
DPM.AX income_statement (annual, 2024-12-31) — Cost Of Revenue: 260701000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 42549000.00
DPM.AX balance_sheet (quarterly, 2024-12-31) — Current Accrued Expenses: 42549000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Current Assets: 1000985000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 4596000.00
DPM.AX balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 4596000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 4596000.00
DPM.AX balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 4596000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Current Liabilities: 83486000.00
DPM.AX cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 94510000.00
DPM.AX cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 94510000.00
DPM.AX income_statement (annual, 2024-12-31) — Diluted Average Shares: 180441243.00
DPM.AX income_statement (annual, 2024-12-31) — Diluted EPS: 1.31
DPM.AX income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 235880000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Dividends Payable: 7069000.00
DPM.AX balance_sheet (quarterly, 2024-12-31) — Dividends Payable: 7069000.00
DPM.AX income_statement (annual, 2024-12-31) — EBIT: 277697000.00
DPM.AX income_statement (annual, 2024-12-31) — EBITDA: 372207000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Employee Benefits: 18678000.00
DPM.AX cash_flow (annual, 2024-12-31) — End Cash Position: 634830000.00
DPM.AX cash_flow (annual, 2024-12-31) — Financing Cash Flow: -83087000.00
DPM.AX cash_flow (annual, 2024-12-31) — Free Cash Flow: 115813000.00
DPM.AX cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 9525000.00
DPM.AX cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of Business: 7461000.00
DPM.AX income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 995000.00
DPM.AX income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: 2302000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -1427000.00
DPM.AX income_statement (annual, 2024-12-31) — General And Administrative Expense: 41301000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 16295000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Gross PPE: 1105732000.00
DPM.AX balance_sheet (quarterly, 2024-12-31) — Gross PPE: 1105732000.00
DPM.AX income_statement (annual, 2024-12-31) — Gross Profit: 346291000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Income Tax Payable: 6295000.00
DPM.AX income_statement (annual, 2024-12-31) — Interest Expense: 1570000.00
DPM.AX income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 1570000.00
DPM.AX income_statement (annual, 2024-12-31) — Interest Income: 34640000.00
DPM.AX income_statement (annual, 2024-12-31) — Interest Income Non Operating: 34640000.00
DPM.AX cash_flow (annual, 2024-12-31) — Interest Paid Cff: -1999000.00
DPM.AX cash_flow (annual, 2024-12-31) — Interest Received Cfo: 32376000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Inventory: 32945000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Invested Capital: 1286828000.00
DPM.AX cash_flow (annual, 2024-12-31) — Investing Cash Flow: -23904000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 2759000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Investments And Advances: 2759000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 8925000.00
DPM.AX balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 8925000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 8925000.00
DPM.AX balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 8925000.00
DPM.AX cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -6785000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Long Term Provisions: 23288000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 508522000.00
DPM.AX balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 508522000.00
DPM.AX cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 33714000.00
DPM.AX cash_flow (quarterly, 2024-12-31) — Net Business Purchase And Sale: 0.00
DPM.AX cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -49881000.00
DPM.AX cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 0.00
DPM.AX income_statement (annual, 2024-12-31) — Net Income: 235880000.00
DPM.AX income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 235880000.00
DPM.AX income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 243240000.00
DPM.AX income_statement (annual, 2024-12-31) — Net Income Discontinuous Operations: -7360000.00
DPM.AX income_statement (quarterly, 2024-12-31) — Net Income Discontinuous Operations: 4700000.00
DPM.AX income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 235880000.00
DPM.AX income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 243240000.00
DPM.AX cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 268767000.00
DPM.AX income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 235880000.00
DPM.AX income_statement (annual, 2024-12-31) — Net Interest Income: 31542000.00
DPM.AX cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -3675000.00
DPM.AX cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -6785000.00
DPM.AX cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -6785000.00
DPM.AX income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 31542000.00
DPM.AX cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -25317000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Net PPE: 387341000.00
DPM.AX cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: 273000.00
DPM.AX cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: 106000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 1270533000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 8529000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 0.00
DPM.AX balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Liabilities: 0.00
DPM.AX balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 8529000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 0.00
DPM.AX balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Liabilities: 0.00
DPM.AX balance_sheet (annual, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 3056000.00
DPM.AX balance_sheet (quarterly, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 3056000.00
DPM.AX income_statement (annual, 2024-12-31) — Normalized EBITDA: 364311000.00
DPM.AX income_statement (annual, 2024-12-31) — Normalized Income: 236284421.44
DPM.AX cash_flow (annual, 2024-12-31) — Operating Cash Flow: 144712000.00
DPM.AX cash_flow (annual, 2024-12-31) — Operating Gains Losses: 16986000.00
DPM.AX income_statement (annual, 2024-12-31) — Operating Income: 237072000.00
DPM.AX income_statement (annual, 2024-12-31) — Operating Revenue: 606992000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 176713839.00
DPM.AX balance_sheet (annual, 2024-12-31) — Other Current Assets: 7485000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 2554000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -1427000.00
DPM.AX income_statement (annual, 2024-12-31) — Other Gand A: 41301000.00
DPM.AX income_statement (annual, 2024-12-31) — Other Income Expense: 7513000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 16295000.00
DPM.AX balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 16295000.00
DPM.AX cash_flow (annual, 2024-12-31) — Other Non Cash Items: -28782000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 5296000.00
DPM.AX income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -383000.00
DPM.AX income_statement (annual, 2024-12-31) — Other Operating Expenses: 67918000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Other Payable: 6470000.00
DPM.AX balance_sheet (quarterly, 2024-12-31) — Other Payable: 6470000.00
DPM.AX income_statement (annual, 2024-12-31) — Other Taxes: 0.00
DPM.AX balance_sheet (annual, 2024-12-31) — Payables: 27317000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 69866000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 6470000.00
DPM.AX balance_sheet (quarterly, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 6470000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Prepaid Assets: 4306000.00
DPM.AX balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 4306000.00
DPM.AX income_statement (annual, 2024-12-31) — Pretax Income: 276127000.00
DPM.AX cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 4497000.00
DPM.AX cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
DPM.AX cash_flow (annual, 2024-12-31) — Purchase Of Investment: -3675000.00
DPM.AX cash_flow (quarterly, 2024-12-31) — Purchase Of Investment: 0.00
DPM.AX balance_sheet (annual, 2024-12-31) — Raw Materials: 32945000.00
DPM.AX balance_sheet (quarterly, 2024-12-31) — Raw Materials: 32945000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Receivables: 321419000.00
DPM.AX income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 260701000.00
DPM.AX income_statement (annual, 2024-12-31) — Reconciled Depreciation: 94510000.00
DPM.AX cash_flow (annual, 2024-12-31) — Repayment Of Debt: -6785000.00
DPM.AX cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -49881000.00
DPM.AX income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: -6901000.00
DPM.AX income_statement (quarterly, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
DPM.AX balance_sheet (annual, 2024-12-31) — Retained Earnings: 734759000.00
DPM.AX cash_flow (annual, 2024-12-31) — Sale Of Business: 33714000.00
DPM.AX cash_flow (quarterly, 2024-12-31) — Sale Of Business: 0.00
DPM.AX cash_flow (annual, 2024-12-31) — Sale Of PPE: 273000.00
DPM.AX cash_flow (quarterly, 2024-12-31) — Sale Of PPE: 106000.00
DPM.AX income_statement (annual, 2024-12-31) — Selling General And Administration: 41301000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Share Issued: 176713839.00
DPM.AX income_statement (annual, 2024-12-31) — Special Income Charges: 6901000.00
DPM.AX income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
DPM.AX cash_flow (annual, 2024-12-31) — Stock Based Compensation: 852000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Stockholders Equity: 1286828000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Tangible Book Value: 1270533000.00
DPM.AX income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 940421.44
DPM.AX income_statement (annual, 2024-12-31) — Tax Provision: 32887000.00
DPM.AX income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.12
DPM.AX balance_sheet (annual, 2024-12-31) — Taxes Receivable: 12799000.00
DPM.AX balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 12799000.00
DPM.AX cash_flow (annual, 2024-12-31) — Taxes Refund Paid: -28603000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Total Assets: 1421205000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Total Capitalization: 1286828000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Total Debt: 13521000.00
DPM.AX balance_sheet (quarterly, 2024-12-31) — Total Debt: 13521000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 1286828000.00
DPM.AX income_statement (annual, 2024-12-31) — Total Expenses: 369920000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 134377000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 420220000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 50891000.00
DPM.AX income_statement (annual, 2024-12-31) — Total Other Finance Cost: 1528000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Total Tax Payable: 11987000.00
DPM.AX income_statement (annual, 2024-12-31) — Total Unusual Items: 7896000.00
DPM.AX income_statement (quarterly, 2024-12-31) — Total Unusual Items: 2302000.00
DPM.AX income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 7896000.00
DPM.AX income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 2302000.00
DPM.AX balance_sheet (annual, 2024-12-31) — Working Capital: 917499000.00
DPM.AX income_statement (quarterly, 2025-03-31) — +Operating Expense: 29387000.00
DPM.AX income_statement (quarterly, 2025-03-31) — +Total Revenue: 144147000.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 102627000.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 192426000.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 5850000.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 3580000.00
DPM.AX income_statement (quarterly, 2025-03-31) — Basic Average Shares: 176336842.00
DPM.AX income_statement (quarterly, 2025-03-31) — Basic EPS: 0.19
DPM.AX cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 634830000.00
DPM.AX cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -4194000.00
DPM.AX cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -4194000.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Capital Stock: 525013000.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 763026000.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 763026000.00
DPM.AX cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -7069000.00
DPM.AX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -91464000.00
DPM.AX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -8502000.00
DPM.AX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 228162000.00
DPM.AX cash_flow (quarterly, 2025-03-31) — Change In Inventory: -796000.00
DPM.AX cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: 12875000.00
DPM.AX cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 18902000.00
DPM.AX cash_flow (quarterly, 2025-03-31) — Change In Receivables: 133512000.00
DPM.AX cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 164493000.00
DPM.AX cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 133512000.00
DPM.AX cash_flow (quarterly, 2025-03-31) — Changes In Cash: 128196000.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Common Stock: 525013000.00
DPM.AX cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -7069000.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 1230208000.00
DPM.AX cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -82279000.00
DPM.AX income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 59549000.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Current Assets: 989756000.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 120525000.00
DPM.AX cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 20172000.00
DPM.AX cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 20172000.00
DPM.AX income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 176336842.00
DPM.AX income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.19
DPM.AX income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 33504000.00
DPM.AX income_statement (quarterly, 2025-03-31) — EBIT: 39264000.00
DPM.AX income_statement (quarterly, 2025-03-31) — EBITDA: 59436000.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Employee Benefits: 24293000.00
DPM.AX cash_flow (quarterly, 2025-03-31) — End Cash Position: 763026000.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Financial Assets: 47000.00
DPM.AX cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -91464000.00
DPM.AX cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 223968000.00
DPM.AX cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 8836000.00
DPM.AX income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -1002000.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -577000.00
DPM.AX income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 17037000.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 15495000.00
DPM.AX income_statement (quarterly, 2025-03-31) — Gross Profit: 84598000.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 10515000.00
DPM.AX income_statement (quarterly, 2025-03-31) — Interest Expense: 712000.00
DPM.AX income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 712000.00
DPM.AX income_statement (quarterly, 2025-03-31) — Interest Income: 8568000.00
DPM.AX income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 8568000.00
DPM.AX cash_flow (quarterly, 2025-03-31) — Interest Paid Cff: -327000.00
DPM.AX cash_flow (quarterly, 2025-03-31) — Interest Received Cfo: 8121000.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Inventory: 32967000.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Invested Capital: 1230208000.00
DPM.AX cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -8502000.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 3580000.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 3580000.00
DPM.AX cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -1324000.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 24391000.00
DPM.AX cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -82279000.00
DPM.AX income_statement (quarterly, 2025-03-31) — Net Income: 33504000.00
DPM.AX income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 33504000.00
DPM.AX income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 33504000.00
DPM.AX income_statement (quarterly, 2025-03-31) — Net Income Discontinuous Operations: 0.00
DPM.AX income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 33504000.00
DPM.AX income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 33504000.00
DPM.AX cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 38552000.00
DPM.AX income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 33504000.00
DPM.AX income_statement (quarterly, 2025-03-31) — Net Interest Income: 7856000.00
DPM.AX cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 0.00
DPM.AX cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -1324000.00
DPM.AX cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -1324000.00
DPM.AX income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 7856000.00
DPM.AX cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -984000.00
DPM.AX cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -4308000.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Net PPE: 389078000.00
DPM.AX cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: 0.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 1214713000.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 7415000.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 7415000.00
DPM.AX income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 59436000.00
DPM.AX income_statement (quarterly, 2025-03-31) — Normalized Income: 33504000.00
DPM.AX cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 228162000.00
DPM.AX cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 8836000.00
DPM.AX income_statement (quarterly, 2025-03-31) — Operating Income: 55211000.00
DPM.AX income_statement (quarterly, 2025-03-31) — Operating Revenue: 144147000.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 169370208.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 1337000.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 7383000.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -577000.00
DPM.AX income_statement (quarterly, 2025-03-31) — Other Gand A: 17037000.00
DPM.AX income_statement (quarterly, 2025-03-31) — Other Income Expense: -24515000.00
DPM.AX cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -12536000.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 5417000.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 11371000.00
DPM.AX income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -24515000.00
DPM.AX income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 12350000.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Payables: 113142000.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 113142000.00
DPM.AX income_statement (quarterly, 2025-03-31) — Pretax Income: 38552000.00
DPM.AX cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 519000.00
DPM.AX cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: 0.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Receivables: 192426000.00
DPM.AX income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 59549000.00
DPM.AX income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 20172000.00
DPM.AX cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -1324000.00
DPM.AX cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -82279000.00
DPM.AX income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 0.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 699922000.00
DPM.AX cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 0.00
DPM.AX income_statement (quarterly, 2025-03-31) — Selling General And Administration: 17037000.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Share Issued: 169370208.00
DPM.AX income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
DPM.AX cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 205000.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 1230208000.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 1214713000.00
DPM.AX income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
DPM.AX income_statement (quarterly, 2025-03-31) — Tax Provision: 5048000.00
DPM.AX income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.13
DPM.AX cash_flow (quarterly, 2025-03-31) — Taxes Refund Paid: 319000.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Total Assets: 1410788000.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 1230208000.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 1230208000.00
DPM.AX income_statement (quarterly, 2025-03-31) — Total Expenses: 88936000.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 180580000.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 421032000.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 60055000.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 10515000.00
DPM.AX income_statement (quarterly, 2025-03-31) — Total Unusual Items: -1002000.00
DPM.AX income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -1002000.00
DPM.AX balance_sheet (quarterly, 2025-03-31) — Working Capital: 869231000.00
DPM.AX income_statement (quarterly, 2025-06-30) — +Operating Expense: 24091000.00
DPM.AX income_statement (quarterly, 2025-06-30) — +Total Revenue: 186487000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 107281000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 199677000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 5946000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 2861000.00
DPM.AX income_statement (quarterly, 2025-06-30) — Basic Average Shares: 168161224.00
DPM.AX income_statement (quarterly, 2025-06-30) — Basic EPS: 0.49
DPM.AX cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 763026000.00
DPM.AX cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -2392000.00
DPM.AX cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -2392000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Capital Stock: 518019000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 331685000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 331685000.00
DPM.AX cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -6775000.00
DPM.AX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -42072000.00
DPM.AX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -483481000.00
DPM.AX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 94212000.00
DPM.AX cash_flow (quarterly, 2025-06-30) — Change In Inventory: 1435000.00
DPM.AX cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -2437000.00
DPM.AX cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 69000.00
DPM.AX cash_flow (quarterly, 2025-06-30) — Change In Receivables: -6720000.00
DPM.AX cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -7653000.00
DPM.AX cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -6720000.00
DPM.AX cash_flow (quarterly, 2025-06-30) — Changes In Cash: -431341000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Common Stock: 518019000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 1272775000.00
DPM.AX cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -33856000.00
DPM.AX income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 70161000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Current Assets: 1030840000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 124542000.00
DPM.AX cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 23691000.00
DPM.AX cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 23691000.00
DPM.AX income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 168161224.00
DPM.AX income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.49
DPM.AX income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 82399000.00
DPM.AX income_statement (quarterly, 2025-06-30) — EBIT: 93104000.00
DPM.AX income_statement (quarterly, 2025-06-30) — EBITDA: 116795000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 16937000.00
DPM.AX cash_flow (quarterly, 2025-06-30) — End Cash Position: 331685000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Financial Assets: 34000.00
DPM.AX cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -42072000.00
DPM.AX cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 91820000.00
DPM.AX cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: 5631000.00
DPM.AX income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -3389000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -1353000.00
DPM.AX income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 10576000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 14767000.00
DPM.AX income_statement (quarterly, 2025-06-30) — Gross Profit: 116326000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 9274000.00
DPM.AX income_statement (quarterly, 2025-06-30) — Interest Expense: 1100000.00
DPM.AX income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 1100000.00
DPM.AX income_statement (quarterly, 2025-06-30) — Interest Income: 7849000.00
DPM.AX income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 7849000.00
DPM.AX cash_flow (quarterly, 2025-06-30) — Interest Paid Cff: -366000.00
DPM.AX cash_flow (quarterly, 2025-06-30) — Interest Received Cfo: 8077000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Inventory: 30987000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Invested Capital: 1272775000.00
DPM.AX cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -483481000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 2861000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 2861000.00
DPM.AX cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -1482000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 26433000.00
DPM.AX cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -33856000.00
DPM.AX income_statement (quarterly, 2025-06-30) — Net Income: 82399000.00
DPM.AX income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 82399000.00
DPM.AX income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 82399000.00
DPM.AX income_statement (quarterly, 2025-06-30) — Net Income Discontinuous Operations: 0.00
DPM.AX income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 82399000.00
DPM.AX income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 82399000.00
DPM.AX cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 92004000.00
DPM.AX income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 82399000.00
DPM.AX income_statement (quarterly, 2025-06-30) — Net Interest Income: 6749000.00
DPM.AX cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 841000.00
DPM.AX cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -1482000.00
DPM.AX cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -1482000.00
DPM.AX income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 6749000.00
DPM.AX cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -481930000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Net PPE: 390806000.00
DPM.AX cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: 0.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 1258008000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 7499000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 7499000.00
DPM.AX income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 125314000.00
DPM.AX income_statement (quarterly, 2025-06-30) — Normalized Income: 90028636.55
DPM.AX cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 94212000.00
DPM.AX cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 5631000.00
DPM.AX income_statement (quarterly, 2025-06-30) — Operating Income: 92235000.00
DPM.AX income_statement (quarterly, 2025-06-30) — Operating Revenue: 186487000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 166933140.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 468491000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 7987000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -1353000.00
DPM.AX income_statement (quarterly, 2025-06-30) — Other Gand A: 10576000.00
DPM.AX income_statement (quarterly, 2025-06-30) — Other Income Expense: -6980000.00
DPM.AX cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -14603000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 5488000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 11608000.00
DPM.AX income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 1539000.00
DPM.AX income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 13515000.00
DPM.AX income_statement (quarterly, 2025-06-30) — Other Taxes: 0.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Payables: 116555000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 116555000.00
DPM.AX income_statement (quarterly, 2025-06-30) — Pretax Income: 92004000.00
DPM.AX cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 407000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Receivables: 199677000.00
DPM.AX income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 70161000.00
DPM.AX income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 23691000.00
DPM.AX cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -1482000.00
DPM.AX cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -33856000.00
DPM.AX income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 5130000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 750163000.00
DPM.AX cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 0.00
DPM.AX income_statement (quarterly, 2025-06-30) — Selling General And Administration: 10576000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Share Issued: 166933140.00
DPM.AX income_statement (quarterly, 2025-06-30) — Special Income Charges: -5130000.00
DPM.AX cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 236000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 1272775000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 1258008000.00
DPM.AX income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -889363.45
DPM.AX income_statement (quarterly, 2025-06-30) — Tax Provision: 9605000.00
DPM.AX income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.10
DPM.AX cash_flow (quarterly, 2025-06-30) — Taxes Refund Paid: -13171000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Total Assets: 1452295000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 1272775000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 1272775000.00
DPM.AX income_statement (quarterly, 2025-06-30) — Total Expenses: 94252000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 179520000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 421455000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 54978000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 9274000.00
DPM.AX income_statement (quarterly, 2025-06-30) — Total Unusual Items: -8519000.00
DPM.AX income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -8519000.00
DPM.AX balance_sheet (quarterly, 2025-06-30) — Working Capital: 906298000.00
DPM.AX income_statement (quarterly, 2025-09-30) — +Operating Expense: 38684000.00
DPM.AX income_statement (quarterly, 2025-09-30) — +Total Revenue: 267413000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 227570000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 209268000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 6156000.00
DPM.AX cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 25470000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 3328000.00
DPM.AX income_statement (quarterly, 2025-09-30) — Basic Average Shares: 177750000.00
DPM.AX income_statement (quarterly, 2025-09-30) — Basic EPS: 0.54
DPM.AX cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 331685000.00
DPM.AX cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -7571000.00
DPM.AX cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -7571000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Capital Stock: 1580281000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 413611000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 413611000.00
DPM.AX cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -6677000.00
DPM.AX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -146215000.00
DPM.AX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 43565000.00
DPM.AX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 184576000.00
DPM.AX cash_flow (quarterly, 2025-09-30) — Change In Inventory: 3787000.00
DPM.AX cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 19177000.00
DPM.AX cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 1878000.00
DPM.AX cash_flow (quarterly, 2025-09-30) — Change In Receivables: 4219000.00
DPM.AX cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 29061000.00
DPM.AX cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 4219000.00
DPM.AX cash_flow (quarterly, 2025-09-30) — Changes In Cash: 81926000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Common Stock: 1580281000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 2423381000.00
DPM.AX cash_flow (quarterly, 2025-09-30) — Common Stock Payments: 0.00
DPM.AX income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 113847000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Current Assets: 694477000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 250384000.00
DPM.AX cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 28181000.00
DPM.AX cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 28181000.00
DPM.AX income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 177750000.00
DPM.AX income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.54
DPM.AX income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 95985000.00
DPM.AX income_statement (quarterly, 2025-09-30) — EBIT: 110196000.00
DPM.AX income_statement (quarterly, 2025-09-30) — EBITDA: 138377000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Employee Benefits: 25904000.00
DPM.AX cash_flow (quarterly, 2025-09-30) — End Cash Position: 413611000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Financial Assets: 55000.00
DPM.AX cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -146215000.00
DPM.AX cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 177005000.00
DPM.AX cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 3960000.00
DPM.AX cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of Business: 0.00
DPM.AX income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -580000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -309000.00
DPM.AX income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 21677000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 13589000.00
DPM.AX income_statement (quarterly, 2025-09-30) — Gross Profit: 153566000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 9175000.00
DPM.AX income_statement (quarterly, 2025-09-30) — Interest Expense: 1805000.00
DPM.AX income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 1805000.00
DPM.AX income_statement (quarterly, 2025-09-30) — Interest Income: 8493000.00
DPM.AX income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 8493000.00
DPM.AX cash_flow (quarterly, 2025-09-30) — Interest Paid Cff: -1483000.00
DPM.AX cash_flow (quarterly, 2025-09-30) — Interest Received Cfo: 9141000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Inventory: 69804000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Invested Capital: 2423381000.00
DPM.AX cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 43565000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 3328000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 3328000.00
DPM.AX cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -138076000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 37597000.00
DPM.AX cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: -399152000.00
DPM.AX cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
DPM.AX income_statement (quarterly, 2025-09-30) — Net Income: 95985000.00
DPM.AX income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 95985000.00
DPM.AX income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 95985000.00
DPM.AX income_statement (quarterly, 2025-09-30) — Net Income Discontinuous Operations: 0.00
DPM.AX income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 95985000.00
DPM.AX income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 95985000.00
DPM.AX cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 108391000.00
DPM.AX income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 95985000.00
DPM.AX income_statement (quarterly, 2025-09-30) — Net Interest Income: 6688000.00
DPM.AX cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -171000.00
DPM.AX cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -138076000.00
DPM.AX cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -138076000.00
DPM.AX income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 6688000.00
DPM.AX cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 450459000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Net PPE: 2210683000.00
DPM.AX cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: 0.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 2409792000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 7311000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 152665000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 7311000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 152665000.00
DPM.AX income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 149233000.00
DPM.AX income_statement (quarterly, 2025-09-30) — Normalized Income: 105598465.69
DPM.AX cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 184576000.00
DPM.AX cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 3960000.00
DPM.AX income_statement (quarterly, 2025-09-30) — Operating Income: 114882000.00
DPM.AX income_statement (quarterly, 2025-09-30) — Operating Revenue: 267413000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 221880802.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 1794000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 13639000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -309000.00
DPM.AX income_statement (quarterly, 2025-09-30) — Other Gand A: 21677000.00
DPM.AX income_statement (quarterly, 2025-09-30) — Other Income Expense: -13179000.00
DPM.AX cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -7639000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 7275000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 46787000.00
DPM.AX income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -2323000.00
DPM.AX income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 17007000.00
DPM.AX income_statement (quarterly, 2025-09-30) — Other Taxes: 0.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Payables: 236745000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 236745000.00
DPM.AX income_statement (quarterly, 2025-09-30) — Pretax Income: 108391000.00
DPM.AX cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 21000.00
DPM.AX cash_flow (quarterly, 2025-09-30) — Purchase Of Business: -399152000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Receivables: 209268000.00
DPM.AX income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 113847000.00
DPM.AX income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 28181000.00
DPM.AX cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -138076000.00
DPM.AX cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: 0.00
DPM.AX income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 10276000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 837253000.00
DPM.AX cash_flow (quarterly, 2025-09-30) — Sale Of Business: 0.00
DPM.AX cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 0.00
DPM.AX income_statement (quarterly, 2025-09-30) — Selling General And Administration: 21677000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Share Issued: 221880802.00
DPM.AX income_statement (quarterly, 2025-09-30) — Special Income Charges: -10276000.00
DPM.AX cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 234000.00
DPM.AX balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 2423381000.00